drugset / Trial / NCT02951845
Study to Investigate the Food Effect and Oral Bioavailability of Tablet Formulations Relative to Suspension Formulation of JNJ-54416076 in Healthy Participants
RandomizedCrossoverOpen-labelTreatment
Summary
The purpose of the study is to assess the oral bioavailability of the two tablet formulations of JNJ-54416076 relative to the suspension formulation and to investigate the effect of a high fat meal on the pharmacokinetics of the tablet formulation in healthy participants.
Timeline
- Start
- 2016-11-22
- Primary completion
- 2017-02-17
- Completion
- 2017-02-17
Outcome
Outcome not reported
Stopped (Business): “JNJ-54416076 program has been stopped for strategic business reasons.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | JNJ-54416076 | Unknown | 25 mg | Oral |
Indications
No indication recorded.